| |
Afrikaanse
weergawe/This site in Afrikaans
THE DIAGNOSIS OF MARFAN SYNDROME (Revised 2010)
The diagnosis of Marfan syndrome is based on the systemic
features (signs and symptoms in the organ systems). The
revised method (2010) assigns points to relevant features and
the final score for the patient is used to decide on the
diagnosis.
Contents of this webpage (click on required section)
GENETICS AND CONNECTIVE TISSUE
Marfan syndrome is a genetic disorder of connective tissue. Fibrillin in
elastin is
faulty due to a mutation (alteration) in the
FBN1 gene on chromosome15. Connective tissue, containing
elastin, is found throughout the body and the effects of the
faulty fibrillin are therefore found in all organ systems.
The disorder is an autosomal dominant genetic disorder, which
means that it is passed from parent to child, without any
unaffected carriers and it never skips a generation. Every
child of a person with Marfan syndrome has a 50% chance of
having it. It is very variable in both severity and in the
features that are significant in a patient - even in one
family. Sometimes there is a spontaneous mutation, where there
is no sign of the disorder in the family. These patients are
usually very seriously affected and can pass it on to their
children by the usual autosomal dominant method.
The possible features of Marfan syndrome, including the
family history and mutations of the gene for fibrillin,
are listed below.
FEATURES OF MARFAN SYDROME
Some features common in Marfan syndrome are also found in
other disorders and are therefore not used in the scoring for
the diagnosis. (Brief descriptions of the features can be
found on the Definitions page of this website. Click on the
term in colour and underlined to go direct to the
definition.)
Family and genetic history
- Having a parent, child or sibling who meets the
diagnostic criteria independently.
- Presence of a mutation in FBN1 known to cause Marfan
syndrome. (Technical information below.)
Criteria for causal FBN1 mutation (technical information about the mutation):
- Mutation previously shown to segregate in the Marfan
family
- De novo (with proven paternity and absence of disease in
parents) mutation in one of the following categories:
- Nonsense mutation.
- Inframe and out of frame deletion/insertion.
- Splice site mutations affecting canonical splice
sequences or shown to alter splicing on mRNA/cDNA level.
- Missense affecting/creating cysteine residues.
- Missense affecting conserved residues of the EGF
consensus sequence [(D/N)X(D/N)(E/Q)Xm(D/N)Xn(Y/F), m and
n = variable number residues: D aspartic acid, N
asparagine, E glutamic acid, Q glutamine, Y tyrosine, F
phenylalanine].
- Other missense mutations: segregation in family if
possible + absence in 400 ethnically matched control
chromosomes; or if no family history, absence in 400
ethnically matched control chromosomes.
- Linkage of haplotype for n≥6 meioses to the FBN1
locus.
Cardiovascular system
- Aortic root aneurysm or dissection
- Mitral valve prolapse
- Dilation or dissection of the descending thoracic or
abdominal aorta (not included in scoring)
- Dilation of the main pulmonary artery (not included in
scoring)
- Calcification of the mitral annulus below the age of 40
(not included in scoring)
Ocular system
- Ectopia lentis
- Myopia
- early onset, high severity, rapid progression
- Abnormally flat cornea (not included in scoring)
- Increased axial length of globe (not included in
scoring)
- Hypoplastic iris or hypoplastic ciliary muscle (not
included in scoring)
- Typical of Marfan syndrome: early cataracts,
open angle glaucoma (not included in scoring)
SYSTEMIC CRITERIA
Skeletal system
Pulmonary system
Dermal system and integument
SCORING OF SYSTEMIC FEATURES
The following are the points allocated to each feature or
combination of features. The total score for a patient (if ≥7)
can then be used for the final diagnosis - see Requirements 3
or 6 below.
| Feature |
Score |
Value |
| Wrist sign AND thumb sign |
3 |
|
| Wrist sign OR thumb sign |
1 |
|
| Pectus carinatum deformity |
2 |
|
| Pectus excavatum or chest asymmetry |
1 |
|
| Hindfoot deformity |
2 |
|
| Flat foot (pes planus) |
1 |
|
| Pneumothorax |
2 |
|
| Dural ectasia |
2 |
|
| Protrusio acetabulae |
2 |
|
Reduced upper segment/lower segment AND
increased armspan/height |
1 |
|
| Scoliosis or thoracolumbar kyphosis |
1 |
|
| Reduced elbow extension |
1 |
|
| 3 of 5 facial features |
1 |
|
| Skin striae |
1 |
|
| Myopia |
1 |
|
| Mitral valve prolapse |
1 |
|
| TOTAL |
|
DIAGNOSIS
Requirements for the diagnosis of Marfan syndrome.
The diagnosis of Marfan syndrome is positive if one of the
following requirements is met:
For the
index case, i.e. in the absence of family history, one of:
- Aortic root aneurysm (Z≥2 above 20 years, Z≥3 below 20
years), or aortic root dissection, AND ectopia lentis.
- Aortic root aneurysm (Z≥2 above 20 years, Z≥3 below 20
years), or aortic root dissection, AND FBN1 mutation.
- Aortic root aneurysm (Z≥2 above 20 years, Z≥3 below 20
years), or aortic root dissection, AND systemic points ≥7.
- Ectopia lentis AND FBN1 mutation, WITH known aortic root
aneurysm (Z<2 above 20 years, Z<3 below 20 years).
For a relative of an index case, i.e. presence of family
history, one of:
- Ectopia lentis AND family history of Marfan syndrome (as
defined above).
- Systemic points ≥7 AND family history of Marfan syndrome
(as defined above).
- Aortic root aneurysm (Z≥2 above 20 years, Z≥3 below 20
years), or aortic root dissection, AND family history of
Marfan syndrome (as defined above).
Conditions to be differentiated from Marfan syndrome
The following disorders overlap, to varying extents, with
Marfan syndrome:
- Loeys-Dietz syndrome
- Bicuspid aortic valve
- Familial thoracic aortic aneurysm
- Vascular Ehlers-Danlos syndrome
- Arterial tortuosity syndrome
- Ectopia lentis syndrome
- Weill-Marchesani syndrome
- Homocystinuria
- Stickler syndrome
- Shprintzen-Goldberg syndrome
- Congenital contractural arachnodactyly (Beals syndrome)
- MASS phenotype (myopia, mitral valve prolapse, mild
aortic dilation, skin striae, and skeletal involvement)
- Mitral valve prolapse syndrome (Barlow syndrome)
Contact SAMSO for more information on the differential
diagnosis of these disorders, or refer to "The revised Ghent
nosology for the Marfan syndrome" by Loeys, Dietz, et al.
Jour. Med Genetics (2010).
This summary was prepared by L P Higgs from "The revised
Ghent nosology for the Marfan syndrome" by Loeys, Dietz, et
al. Jour. Med Genetics (2010) - TEC/002 in the SAMSO
catalogue.
|